EcoCatalytic Technologies (United States)
- Research works
- 1 ▲ 300% vs 2013–17
- Citations
- 33 24.3 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 92% world 28%
Not ranked overall: EcoCatalytic Technologies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does EcoCatalytic Technologies (United States) publish most on?
By volume in 2022–2025: Respiratory and Cough-Related Research, Thyroid Disorders and Treatments and Pharmaceutical studies and practices.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Respiratory and Cough-Related Research Pulmonary and Respiratory Medicine 0 works
- 2 Thyroid Disorders and Treatments Endocrinology, Diabetes and Metabolism 0 works
- 3 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has EcoCatalytic Technologies (United States)'s research output changed?
Output in 2018–2022 was 300% higher than in 2013–2017.
Other research institutions in Monmouth Junction
- Tris Pharma (United States)
- United Silicon Carbide (United States)
- Knite (United States)
- Provid Pharmaceuticals (United States)
- PharmaSeq (United States)
- CytoSorbents (United States)
- Nanonex (United States)
- Diamir (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.